Characterization of the quantitative HCV NASBA assay (Q42995435)

12 November 2017

title

Characterization of the quantitative HCV NASBA assay (English)

1 reference

12 November 2017

Damen M

1

1 reference

12 November 2017

Sillekens P

2

1 reference

12 November 2017

Cuypers HT

3

1 reference

12 November 2017

Frantzen I

4

1 reference

12 November 2017

Melsert R

5

1 reference

12 November 2017

publication date

1 September 1999

1 reference

Journal of Virological Methods

12 November 2017

published in

1 reference

12 November 2017

volume

82

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

45-54

1 reference

Stability of HIV-1 RNA in blood during specimen handling and storage prior to amplification by NASBA-QT

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900079-8

7 January 2021

International collaborative study on the second EUROHEP HCV-RNA reference panel

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900079-8

7 January 2021

Stability of hepatitis C virus RNA during specimen handling and storage prior to NASBA amplification

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900079-8

7 January 2021

Longitudinal study of plasma HIV-1 RNA concentrations during the asymptomatic stage of HIV infection measured using AMPLICOR HIV monitor and NASBA HIV-1 RNA QT tests. ACCTES Association

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900079-8

7 January 2021

Assessment of hepatitis C virus RNA levels by quantitative competitive RNA polymerase chain reaction: high-titer viremia correlates with advanced stage of disease

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900079-8

7 January 2021

Rapid, non-separation electrochemiluminescent DNA hybridization assays for PCR products, using 3'-labelled oligonucleotide probes

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900079-8

7 January 2021

Comparison of plasma virus loads among individuals infected with hepatitis C virus (HCV) genotypes 1, 2, and 3 by quantiplex HCV RNA assay versions 1 and 2, Roche Monitor assay, and an in-house limiting dilution method

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900079-8

7 January 2021

Serum HCV RNA levels assessed by quantitative NASBA: stability of viral load over time, and lack of correlation with liver disease. The Trent HCV Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900079-8

7 January 2021

Significance of serum hepatitis C virus RNA levels in chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900079-8

7 January 2021

Possible role of high-titer maternal viremia in perinatal transmission of hepatitis C virus.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900079-8

7 January 2021

Geographical distribution of hepatitis C virus genotypes in blood donors: an international collaborative survey

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900079-8

7 January 2021

Clinical characterization of a competitive PCR assay for quantitative testing of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900079-8

7 January 2021

Transmission of hepatitis C virus from mothers to infants. The Vertical Transmission of Hepatitis C Virus Collaborative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900079-8

7 January 2021

Plasma virus load evaluation in relation to disease progression in HIV-infected children

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2899%2900079-8

7 January 2021

10.1016/S0166-0934(99)00079-8

Identifiers

DOI

1 reference

12 November 2017

1 reference